TennesseeSB 2549114th General Assembly (2025-2026)SenateWALLET

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to buprenorphine products.

Sponsored By: Sponsor information unavailable

Signed by Governor

Opioids

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Expanded provider category for correctional health workers

The law expands a health provider category in Tennessee’s buprenorphine rules. It includes people employed by, contracting with, or subcontracting through a contracted healthcare vendor serving Tennessee prisons or county or city jails. These people must provide healthcare services. The change took effect upon becoming law and does not set payment amounts or require specific treatment.

Sponsors & Cosponsors

Sponsors

There is no primary sponsor on record.

Cosponsors

  • Jeff Yarbro

    Democrat • Senate

Roll Call Votes

All Roll Calls

Yes: 38 • No: 2

Senate vote • 3/16/2026

FLOOR VOTE: Third Consideration 3/16/2026

Yes: 30 • No: 1

Senate vote • 3/4/2026

SENATE HEALTH AND WELFARE COMMITTEE

Yes: 8 • No: 1

Bill Text

  • Enrolled / Public Chapter

  • Fiscal Note

  • Introduced

Related Bills

Back to State Legislation